Chronic Leukaemias

Prospective Clinical Trials Retrospective Studies Members Publications Questionnaire Study Administration

CML RELAPSE TRIAL

Phase III randomized study of donor lymphocyte infusions vs Imatinib followed by donor lymphocyte infusions for relapse after allogeneic blood or marrow transplant for Chronic Myeloid Leukemia

Trial management:

Trial Co-ordination and Data Management:
Alain Barrois (EBMT Clinical Trials Office Leiden)
Tel: +31 71 526 9722

Coordinating investigators:
Cesare Guglielmi (Rome)

Statistician:
Ronald Brand (Leiden)

 

This study has been cancelled last at the last subcommittee chair meeting in Leiden (29 November 2006)